VTE Risk Tripled in Systemic Sclerosis (CME/CE)
(MedPage Today) -- Risk is highest in the first year after diagnosis. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 22, 2015 Category: Cardiology Source Type: news

Woman with systemic scleroderma details how disease is destroying her body
Chanel White was a 20-years-old newlywed just off her honeymoon when she was diagnosed with systemic scleroderma, a disease characterized by the hardening of the skin and connective tissues. (Source: the Mail online | Health)
Source: the Mail online | Health - July 17, 2015 Category: Consumer Health News Source Type: news

Silica Exposure Risky for Men With Scleroderma (CME/CE)
(MedPage Today) -- If your patient has scleroderma, ask about silica exposure this study suggested (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - July 13, 2015 Category: Rheumatology Source Type: news

A Better Way to Spot Pulmonary HTN in Systemic Sclerosis? (CME/CE)
(MedPage Today) -- Elevated cardiac troponin/probrain natriuretic peptide linked to risk of lethal complication (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - June 30, 2015 Category: Cardiology Source Type: news

Fractures and Systemic Sclerosis: The Risk Is High (CME/CE)
(MedPage Today) -- Patients, and women in particular, should be evaluated for osteoporosis risk (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - June 25, 2015 Category: Primary Care Source Type: news

EULAR: Updated scleroderma guidance focuses on new treatments, approaches
ROME – Updated expert recommendations from the European League Against Rheumatism for the treatment of systemic sclerosis will focus on several new treatment options, although the use of biologic agents is not included in detail because there are still too few data on these drugs to give firm... (Source: Skin and Allergy News)
Source: Skin and Allergy News - June 23, 2015 Category: Dermatology Tags: FPN Conferences IMN Conferences RHEUM Conference News SAN Conference News FPN News IMN News RHEUM News Source Type: news

Cancer Risk Factors in Patients With Scleroderma Cancer Risk Factors in Patients With Scleroderma
Dr Deane reviews and comments on a recent study evaluating whether demographics and clinical features, such as autoantibody status, are risk factors for cancer in patients with scleroderma. Medscape Rheumatology (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - June 15, 2015 Category: Rheumatology Tags: Rheumatology Viewpoint Source Type: news

Unique Microbial Signature Identified in Systemic SclerosisUnique Microbial Signature Identified in Systemic Sclerosis
Patients with systemic sclerosis have an abundance of bacteria that perpetuate inflammation in other autoimmune disorders, such as Crohn's disease, and not as much commensal bacteria that protect. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 12, 2015 Category: Consumer Health News Tags: Rheumatology News Source Type: news

VIDEO: Do pathogenic intestinal bacteria drive scleroderma GI symptoms?
ROME – Patients with systemic sclerosis who have a range of gastointestinal symptoms and severity have higher amounts of pathogenic bacteria than do normal healthy control patients, according to Dr. Elizabeth Volkmann and her colleagues. They examined the bacterial populations found in the cecal...googletag.display('div-gpt-ad-cta'); (Source: Skin and Allergy News)
Source: Skin and Allergy News - June 11, 2015 Category: Dermatology Tags: IMN Conferences IMN Video Library RHEUM Conference News RHEUM Video Library SAN Conference News SAN Video Library FPN Conferences Source Type: news

Genentech’s Actemra gets FDA breakthrough therapy status for scleroderma
Roche Group subsidiary Genentech has received breakthrough therapy designation from the US Food and Drug Administration (FDA) for its Actemra (tocilizumab) to treat patients with systemic sclerosis (scleroderma). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - June 10, 2015 Category: Pharmaceuticals Source Type: news

Roche says Actemra drug wins breakthrough therapy nod from FDA
ZURICH (Reuters) - Roche said it received breakthrough therapy designation from the U.S. health regulator for its Actemra treatment in systemic sclerosis. (Source: Reuters: Health)
Source: Reuters: Health - June 10, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

Roche receives U.S. FDA breakthrough therapy designation for ACTEMRA/RoACTEMRA in systemic sclerosis, and will present new study results at EULAR 2015
Roche today announced that the U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation (BTD) status to ACTEMRA/RoACTEMRA (tocilizumab) for systemic sclerosis (SSc). (Source: Roche Investor Update)
Source: Roche Investor Update - June 10, 2015 Category: Pharmaceuticals Source Type: news

Roche receives U.S. FDA breakthrough therapy designation for ACTEMRA/RoACTEMRA in systemic sclerosis, and will present new study results at EULAR 2015
Roche today announced that the U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation (BTD) status to ACTEMRA/RoACTEMRA (tocilizumab) for systemic sclerosis (SSc). (Source: Roche Media News)
Source: Roche Media News - June 10, 2015 Category: Pharmaceuticals Source Type: news

Nonprofits launch web campaign to raise awareness about scleroderma
Three North American nonprofit organizations that invest in scleroderma research are jointly trying to raise awareness about the autoimmune disorder. Their efforts include posting information and urging people to pledge to raise awareness about the disease on Facebook and Twitter channels... (Source: Skin and Allergy News)
Source: Skin and Allergy News - June 2, 2015 Category: Dermatology Tags: FPN News FPN Dermatology FPN Rare Diseases FPN Rheumatology IMN News RHEUM News RHEUM Lupus/Connective Tissue Diseases Source Type: news

Bob Saget Shines a Light on Scleroderma With Cool Comedy -- Hot Cuisine
In 1982, management consultant and former competitive figure skater, Sharon Monsky was diagnosed with scleroderma (in Latin "hard skin") a rare, potentially fatal disease that hardens the skin and internal organs and often strikes women of child-bearing age. Given two years to live, Sharon was shocked at how few, even in the medical community, were aware of the disease. Her response was to make possible what seemed impossible. She applied her business expertise to found the Scleroderma Research Foundation (S.R.F.), which, to date, has raised over 35 million dollars and provided medical breakthroughs through tireless res...
Source: Healthy Living - The Huffington Post - May 27, 2015 Category: Consumer Health News Source Type: news